H-group (homology)
3702.1 Penicillin binding protein dimerisation domain
Ligands and drugs
349
Member domains
123
with ligand contacts (≤ 4 Å)
35.2% of members
72
with DrugDomain annotations
20.6% of members
24
with a DrugBank compound
6.9% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 3702.1 belongs to X-group 3702 Penicillin binding protein dimerisation domain, which has 15 proteins with classified ligands. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB08357 | P4G | Diethylene glycol diethyl ether | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CDmetal | CADMIUM ION | 36 |
| CL | CHLORIDE ION | 30 |
| MUR | beta-muramic acid | 15 |
| COmetal | COBALT (II) ION | 6 |
| 1W8 | Ceftaroline | 4 |
| ZNmetal | ZINC ION | 4 |
| AMV | methyl 2-acetamido-3-O-[(1R)-1-carboxyethyl]-2-deoxy-beta-D-glucopyranoside | 2 |
| BR | BROMIDE ION | 2 |
| CAZ | ACYLATED CEFTAZIDIME | 2 |
| QLN | 3-[2-[(~{E})-2-(4-ethynylphenyl)ethenyl]-4-oxidanylidene-quinazolin-3-yl]benzoic acid | 2 |
| QNZ | (E)-3-(2-(4-cyanostyryl)-4-oxoquinazolin-3(4H)-yl)benzoic acid | 2 |
| 12P | DODECAETHYLENE GLYCOL | 1 |
| CEF | CEFOTAXIME, C3' cleaved, open, bound form | 1 |
| MER | (4R,5S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-4-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid | 1 |
| P4G | 1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE | 1 |
| TMO | trimethylamine oxide | 1 |